Webinar Date/Time: Wed, Jul 19, 2023 1:00 PM EDT
This webcast reviews contamination control strategy, how to identify and assess risk, prepare mitigation pathways, and define preventive actions associated with contamination in sterile product manufacturing.
Register Free: https://www.pharmtech.com/pt_w/contamination-control
Event Overview:
Learn more about contamination control strategy (CCS), how to identify and assess risk, prepare mitigation pathways, and define preventive actions associated with contamination in sterile product manufacturing.
Key Learning Objectives
Who Should Attend
Speakers:
Susan Schniepp
Distinguished Fellow - Regulatory Compliance Associates®
Chair of Board of Directors - Parenteral Drug Association® (PDA)
Susan Schniepp is the knowledge leader for Regulatory Compliance Associates® and is Chair of the Parenteral Drug Association (PDA) Board of Directors. Her background includes cGMPs, audit readiness, change control, investigations, supplier quality, and batch record review.
Martell Winters, B.S.
RM/SM (NRCM)
CISS-RAD
Martell Winters is a Director of Science at Nelson Labs and a recognized authority and industry leader on radiation sterilization, bioburden, industrial microbiology, aseptic processing, environmental control, and tissue processing. He has over 25 years of experience on these topics and has worked with clients in all areas of the world speaking, training, and consulting in the medical device, tissue, and pharmaceutical industries. Martell is an active committee member of many working groups within AAMI.
Register Free: https://www.pharmtech.com/pt_w/contamination-control
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.